#Cancerimmunotherapies #DrugDevelopment @cellpress
Understanding Role of #Bcells in the #tumormicroenvironment Multi-faceted organizers, regulators, and effectors of anti-#TumorImmunity
📌 https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00045-4?rss=yes&utm_source=dlvr.it&utm_medium=twitter
📌 https://www.cell.com/cancer-cell/issue?pii=S1535-6108(22)X0006-8

#Cancerimmunotherapies & #interferongamma #ClinicalReview Double-edged roles of IFNγ in tumor elimination and immune escape .Tragetting target IFNγ signaling to overcome immune evasion . A promising therapeutic strategies for the treatment of cancer patient
📌 https://journals.lww.com/jpancreatology/Fulltext/2023/03000/Double_edged_roles_of_IFN__in_tumor_elimination.2.aspx
📌 https://www.cell.com/cell-reports/fulltext/S2211-1247(23)00230-9?rss=yes&utm_source=dlvr.it&utm_medium=twitter#%20

#IDMastodon #oncologyresearch A non-#antibiotic- disrupted #gutmicrobiome is associated with clinical responses to CD19- #CARTcell #CancerImmunotherapy @NatureBiotech
@Elinav_Lab Clinical Evidences from human studies and preclinical experiments have identified the #gutmicrobiome and its effectors as potential major biological variables impacting the efficacy of #CarTcell-driven #Cancerimmunotherapies and their toxicities.
📌 https://www.nature.com/articles/s41591-023-02234-6.pdf